INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.16
arrow_upward
+1.30%(+0.015) 1D
Oct 6, 9:49:07 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.15
High
$1.17
Low
$1.14
Mkt. cap
120.98M
Avg. vol.
3.01M
Volume
118.43K
52-wk high
$2.72
52-wk low
$0.56
EPS
-$1.17
Beta
1.61
Shares outstanding
103.40M
No. of employees
112
Open
$1.15
High
$1.17
Low
$1.14
Mkt. cap
120.98M
Avg. vol.
3.01M
Volume
118.43K
52-wk high
$2.72
52-wk low
$0.56
EPS
-$1.17
Beta
1.61
Shares outstanding
103.40M
No. of employees
112
News stories
From web sources and news partners
Zacks
·
22 hours ago
PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know
AD HOC NEWS
·
23 hours ago
Inovio advances FDA review: Inovio Pharmaceuticals stock falls 3.77 percent
AD HOC NEWS
·
1 day ago
Inovio Pharmaceuticals stock fell 4.13 percent before FDA decision
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc